Birmingham, Alabama 10 January 2012 – Kirchner Private Capital Group (“KPCG” or the “Company”), a leading North American boutique merchant bank, today announced that over the last quarter it has enhanced its management and merger and acquisition teams with the addition of five industry veterans.

“Over the course of the last twenty-seven years we have built a unique platform for small- and medium-size businesses,” said Bud Kirchner, CEO and Founder of Kirchner Private Capital Group. “Our success has been predicated on our ability to attract best-in-class talent and these five individuals are clear examples of this. Collectively, they bring more than 125 years of experience as operators, investors, and transaction experts and they will enhance our platform for the benefit our clients and partners.”

Cameron Davies and Dr. Patrick McNees have joined KPCG as Managing Partners. Mr. Davies joins KPCG with more than a decade of capital market and financial services experience, where he has acted as a trusted advisor to numerous public and private companies and has been a profiled speaker at events targeting the investment community across North America. Dr. McNees leads KPCG’s Health and Life Science Integrated Focus Area and brings more than 35 years of experience as an entrepreneur, advisor, academic, and inventor. He was the founding CEO and Chief Scientist at Applied Health Science, Inc. and co-founder and President of North Rim Systems and Computer Associates, a software firm.

The Company also added seasoned veterans Jack Callaway and Clete Walker as Managing Directors to the M&A team. Mr. Callaway comes to KPCG with decades of investment banking experience including several years as Vice President at NBC Securities Inc., a subsidiary of First American Bank. Mr. Walker brings deep M&A experience to KPCG having executed more than one hundred transactions in his career.

In addition, Vince Krynski has joined the team as a Managing Director with the Transition Management group. Mr. Krynski joins KPCG from Streetlight Intelligence where, as CEO, he led the turnaround of the publicly listed technology company.

“Despite current market conditions we continue to grow and enhance our team with highly experienced professionals,” said Lew Turnquist, Senior Managing Partner. “We have always believed that people and relationships are at the foundation of building a superior platform for small- and medium-sized enterprises. These additions will not only continue to enhance our reach and reputation but, more importantly, will help our clients achieve their operational and transactional objectives.”

-30-

About Kirchner Private Capital Group
Kirchner Private Capital Group is patterned after the original model for a merchant bank. Our team is comprised of successful business people who now apply their operational, transactional and investment experience to the unique needs of early- and mid-stage companies and their investors. We pride ourselves in both the quality and quantity of the long-term relationships we have built over the last 27 years. www.kirchnergroup.com

For further information:
Lew Turnquist
Senior Managing Partner
Phone: +1 (205) 313-0784
lturnquist@kirchnergroup.com

Cameron Davies
Managing Partner
Phone: +1 (416) 420-2861
cdavies@kirchnergroup.com

“I am very pleased to welcome someone with Clete’s experience and reputation to our M&A group,” said W.B. (Bud) Kirchner, CEO and founder of KPCG. “He has successfully completed more than one hundred transactions for small and medium size business and we are looking forward to leveraging his diverse experience across all areas in the firm. His addition continues to demonstrate our commitment to enhancing our capabilities to provide best in class services for our clients.”

KPCG is one of North America’s leading boutique merchant banks focused on all aspects of the small and medium enterprise providing asset management, transaction management and operational management services. Kirchner and Company Inc., the M&A arm of KPCG, provides M&A advisory and transaction management services with a uniquely operational approach.

Clete brings to KPCG his deep M&A experience, having managed more than one hundred transactions in his career. He began as an accountant with Coopers & Lybrand before moving on to operating roles in early-stage growth companies. He was one of the early employees at MedPartners, Inc. / Caremark Rx, Inc. and was Vice President of Finance and Corporate Strategy as it grew to be a multi-billion-dollar company. Clete went on to found three separate companies in the health care arena before serving as President of CFB Investment Co., a venture capital firm, where he also took on turnaround mandates for companies in its portfolio. Most recently he served as Vice President of Development for Surgical Care Affiliates, one of the country’s largest providers of specialty surgical services.

“I am looking forward to working with the exceptionally talented and experienced group of operators, investors, and transaction specialists that have been assembled at KPCG,” said Clete Walker. “Our expanded M&A capabilities position us to build upon KPCG’s reputation as leaders in the private capital space and I look forward to making a strong contribution to the Company’s future growth.”

About Kirchner Private Capital Group
Kirchner Private Capital Group is patterned after the original model for a merchant bank. Our team is comprised of successful business people who now apply their operational, transactional and investment experience to the unique needs of early- and mid-stage companies and their investors. We pride ourselves in both the quality and quantity of the long-term relationships we have built over the last 26 years. www.kirchnergroup.com

For further information:

Lew Turnquist
Senior Managing Partner
Phone: +1 (205) 313-0784
lturnquist@kirchnergroup.com

Kingsport, Tenn., 2 November 2011 – Eastman Renewable Materials, LLC, a wholly-owned subsidiary of Eastman Chemical Company, announced that it has acquired the assets of TetraVitae Bioscience, Inc., located in Chicago, Ill. TetraVitae is a leading developer of renewable chemicals, including bio-based butanol and acetone. Terms of the transaction were not disclosed.

“This announcement is a demonstration of Eastman’s continued investment in innovation and our commitment to delivering sustainable solutions to our customers,” said Dr. Greg W. Nelson, senior vice president and chief technology officer. “I am confident that TetraVitae’s patented bio-catalysis technology will provide Eastman an excellent platform for the development of a range of bio-based processes that will strengthen our sustainable product offerings.”

“This technology is an excellent example of connecting science and sustainability,” said Godefroy Motte, senior vice president and chief regional and sustainability officer. “This acquisition is an important step in our sustainability journey and will go a long way toward helping us meet our goals for sustainably-advantaged products.”

Eastman recently released its 2011 Sustainability Report, which outlines the company’s current progress as well as measurable economic, environmental and social goals. To learn more, visit www.eastman.com/sustainability.

Eastman’s chemicals, fibers and plastics are used as key ingredients in products that people use every day. Approximately 10,000 Eastman employees around the world blend technical expertise and innovation to deliver practical solutions. The company is committed to finding sustainable business opportunities within the diverse markets and geographies it serves. A global company headquartered in Kingsport, Tenn., USA, Eastman had 2010 sales of $5.8 billion. For more information, visit www.eastman.com.

Contacts:
Media:
Tracy Broadwater
423-224-0498 / tkbroadwater@eastman.com

Investors:
Greg Riddle
212-835-1620 / griddle@eastman.com

“We are very pleased to have a person of Cameron’s caliber join the Company,” said Mr. W.B. (Bud) Kirchner, CEO and founder of KPCG. “He is an outstanding leader, and his extensive relationships across the North American investment community, deep knowledge and understanding of the global capital markets and keen eye for product development will serve as key assets to the Company and our clients as we enter the next phase of our growth. We believe the addition of Cameron to our senior management team will enhance our abilities to maximize our opportunities in our chosen target markets.”

In his role as Managing Partner, Mr. Davies will focus on building KPCG’s transition and transaction management businesses. He will work to launch new products and services that add further value to current and prospective KPCG clients, including public and private companies, as well as investors.In addition, Mr. Davies will serve as a key point of contact for the investment community and the Company’s clients, providing an enhanced focused on client relations.

Mr. Davies joins KPCG with more than a decade of capital market and financial services experience, where he has acted as a trusted advisor to numerous public and private companies and has been a profiled speaker at events targeting the investment community across North America. Most recently, he was Senior Vice President at investor relations firm, TMX Equicom (“Equicom”), a wholly-owned subsidiary of the Toronto Stock Exchange. At Equicom, Mr. Davies oversaw numerous groups, helped grow the company’s client base more than 500 percent, was involved in the launch of various new products and services for publicly-listed issuers and acted as a critical member of the team that was responsible for the company’s acquisition by the Toronto Stock Exchange in 2007. He was instrumental in Equicom’s positioning for both strategic and operational success and proved himself as a valued industry advisor. Prior to that, Mr. Davies worked with a Toronto-based technology and life science focused Investment Fund and worked in investment services for the Royal Bank of Canada. Mr. Davies holds a Bachelor of Commerce from McGill University.

“I have spent my career to date building relationships with mid-market companies and the investment community that supports them, and I am excited about being able to better serve them all as a member of the KPCG team,” said Mr. Cameron Davies. “I am looking forward to working with an impressive group of well established professionals and leveraging the excellent KPCG platform to help small- and medium-sized enterprises best achieve their capital markets objectives.”

About Kirchner Private Capital Group
Kirchner Private Capital Group is patterned after the original model for a merchant bank. Our team is comprised of successful business people who now apply their operational, transactional and investment experience to the unique needs of early- and mid-stage companies and their investors. We pride ourselves in both the quality and quantity of the long-term relationships we have built over the last 26 years. www.kirchnergroup.com

For further information:

Lew Turnquist
Senior Managing Partner
Phone: +1 (205) 313-0784
lturnquist@kirchnergroup.com

Cameron Davies
Managing Partner
Phone: +1 (416) 420-2861
cdavies@kirchnergroup.com

KPCG is one of North America’s leading boutique firms focused on all aspects of the small and medium enterprise providing asset management, transaction management and operational transition management services. Kirchner and Company Inc., the M&A arm of KPCG, provides M&A advisory and transaction management services with a uniquely operational approach.

Jack comes to the Kirchner Group after a successful career that has included several years as Vice President of Investment Banking at NBC Securities Inc. a subsidiary of First American Bank, and managing his own independent boutique M&A firm. He began his career as a Certified Public Accountant with Arthur Andersen & Co.

“We are very excited to bring Jack into our M&A group,” said W.B. (Bud) Kirchner, CEO and founder of KPCG. “A veteran like Jack will enhance our already strong and successful team. In addition to an impressive amount of experience, he has complimentary domain expertise that will mesh nicely with our group.”

“I am excited to be joining the Kirchner Group since they share my commitment to helping privately-held businesses through every aspect of their life. I look forward to working closely with the entire Kirchner team” stated Jack.

About Kirchner Private Capital Group
Kirchner Private Capital Group is patterned after the original model for a merchant bank. Our team is comprised of successful business people who now apply their operational, transactional and investment experience to the unique needs of early- and mid-stage companies and their investors. We pride ourselves in both the quality and quantity of the long-term relationships we have built over the last 26 years. www.kirchnergroup.com

For more information please contact:
Lew Turnquist
Senior Managing Partner
Phone: +1 (205) 313-0784
lturnquist@kirchnergroup.com

KPCG is North America’s leading boutique firm focused on all aspects of the small and medium enterprise providing asset management, transaction management and operational transition management services. Kirchner and Company Inc., the M&A arm of KPCG, provides M&A advisory and transaction management services with a uniquely operational approach.

“I am delighted that Lew will now also be heading up our M&A group. It’s a return of sorts to the work he did leading M&A transactions when he first joined us,” said W.B. (Bud) Kirchner, CEO and founder of KPCG. “The growth of our Transition Management group in the short time he has been leading it is testimony to his ability to build businesses. We look forward to working with Lew in his newly expanded role.”

Lew replaces Andy Agrawal as Managing Partner for the M&A group. Andy has resigned but will continue to support the firm’s efforts as the lead on several engagements. “We’re grateful for Andy’s many years of service and wish him the best of success in the future,” added Kirchner.

About Kirchner Private Capital Group

Kirchner Private Capital Group is patterned after the original model for a merchant bank. Our team is comprised of successful business people who now apply their operational, transactional and investment experience to the unique needs of early- and mid-stage companies and their investors. We pride ourselves in both the quality and quantity of the long-term relationships we have built over the last 26 years.  www.kirchnergroup.com

For further information:

Lew Turnquist
Managing Partner
Phone: +1 (205) 313-0784
lturnquist@kirchnergroup.com

15 March 2011 – Sustainable Development Technology Canada (SDTC) and Veolia Environnement Recherche et Innovation announced a formal partnership with the intention to accelerate the commercialization and market uptake of innovative Canadian clean technologies.

Through the partnership, selected entrepreneurs can benefit from the financial resources and business insights of SDTC and the technical, operational and commercial resources of Veolia Environnement (NYSE: VE), one of the world’s largest providers of environmental services in water, waste, public transportation and energy management services.

The partnership builds on an existing relationship, which includes Veolia’s acquisition of Pathogen Detection Systems (PDS) of Kingston, Ontario. PDS received support from SDTC and is now the worldwide headquarters of Veolia’s water sensor subsidiary, ENDETEC

“SDTC and Veolia share a common goal in accelerating the commercialization of promising clean technologies,” stated Vicky Sharpe, President and CEO of Sustainable Development Technology Canada (SDTC). “We are very pleased to deepen our relationship by making Veolia a Cleantech Commercialization Strategic Partner. Veolia has impressive breadth across industry sectors, global reach and the ability to take technologies from the lab to commercial scale.”

Sustainable Development Technology Canada (SDTC) is an arm’s-length foundation created by the Government of Canada with $1.05 billion in funding. SDTC operates two funds aimed at the development and demonstration of innovative technological solutions. The $550 million SD Tech Fund supports projects that address climate change, air quality, clean water, and clean soil. The $500 million NextGen Biofuels Fund supports the establishment of first-of-kind large demonstration-scale facilities for the production of next-generation renewable fuels.

SOURCE: Website: www.sdtc.ca

Dan has 20 years of operating, investment and transaction experience in middle market businesses, serving as executive, board member, investor, fund manager and advisor.  He has completed dozens of financing, acquisition, divestiture, and private equity transactions across a wide range of industries, including consumer, information services, industrial and distribution/logistics.

“We are pleased to add the talent and experience of Dan to the team.  Dan’s private equity and transactional background will nicely complement our growing M&A team.” stated Bud Kirchner, Chairman and Founder of KPCG.

“KPCG has a long history of success leveraging the operating expertise of its team to build and monetize value in small to mid-size companies for investors and executives.  The firm’s relationships and capabilities make it a unique partner for businesses faced with strategic challenges or opportunities.  I look forward to contributing to the firm’s growth and success.” commented Dan.

Most recently, Dan served as President and CEO of a private equity-backed industrial packaging supplier, where he led the company’s expansion into new markets and managed the business successfully through the recent recession.  Previously, Dan played a lead role in developing a private equity investment practice within the corporate holding company of the Ray Hunt family of Dallas, Texas, where he managed investments in operating companies and investment partnerships on behalf of the family and other institutional investors.

Prior to his experience with Hunt, Dan advised public and private companies on corporate finance and M&A transactions, while serving at Credit Suisse First Boston and Dean Witter Reynolds and as a founder of a boutique investment banking firm.  Dan’s track record during this period includes numerous growth capital transactions for high growth companies, from early stage expansion capital to IPOs.

About Kirchner Private Capital Group www.kirchnergroup.com

Kirchner Private Capital Group is patterned after the original model for a merchant bank. Our team is comprised of successful business people who now apply their operational, transactional and investment experience to the unique needs of early- and mid-stage companies and their investors. We pride ourselves in both the quality and quantity of the long-term relationships we have built over the last 25+ years.

For inquiries, please contact:
Andy Agrawal,
Managing Partner
(803) 548-1300
aagrawal@kirchnergroup.com

Exton, Pennsylvania 31 January 2011 – Kensey Nash Corporation (Nasdaq: KNSY), today announced it has acquired the assets of privately held Nerites Corporation, a developer of medical adhesives and anti-fouling coatings based in Madison, Wisconsin for $20 million in cash. Nerites is developing a technology platform of adhesive-based biomaterials which would allow Kensey Nash to further its penetration into the regenerative medicine markets encompassing soft tissue surgical repair, orthopaedics, sports medicine, spine and neurosurgery.

Surgical sealants and adhesives have applications in most surgical procedures. Over the past several years the wound closure market has shifted from early technology such as staples or sutures to next generation technologies as they have become available, including a variety of external and internal surgical adhesives. These products address a market that encompasses over 70 million surgical wounds in the U.S. alone. By 2015, the U.S. medical adhesive and sealant markets are projected to be over $1 billion.

In addition to possible new surgical sealant and adhesive products, Kensey Nash intends to develop and integrate the acquired adhesive, sealant, and coating technologies into its regenerative biomaterials business. The Company believes that access to this technology will enable the Company to develop a portfolio of next generation hybrid adhesive-based products that integrate its ECM, collagen and polymer technology platforms for applications in general, neurologic, plastic/reconstructive, orthopaedic, urologic, cardiovascular and thoracic surgical specialties. Initial product targets include devices for repairing defects in abdominal walls, dural membranes, and gastrointestinal tracts. Revenue from product sales is not expected for at least three to five years.

The Company also intends to explore applications of the Nerites anti-fouling technology for preventing bacterial biofilm formation. Biofilms form when microorganisms attach to implanted medical devices, forming a biological film coating which can interrupt the healing process and result in infection. It is estimated that device-related biofilm infections increase hospital stays and add over one billion dollars per year to U.S. hospitalization costs.

Though the accounting for this transaction has not been finalized, the Company currently expects to account for this transaction as an asset acquisition, with a significant portion of the purchase price expensed in the Company’s third quarter of fiscal 2011 as in-process research and development. The acquisition is expected to be dilutive to earnings by approximately $0.02 per share in the second half of fiscal 2011 (excluding any in-process R&D charges and acquisition costs). The Company currently expects that in fiscal 2012, the acquisition will have a neutral impact on earnings, as any R&D spending on the Nerites technology will be reallocated from other projects.

“We are very excited about this acquisition,” commented Joseph W. Kaufmann, President and CEO of Kensey Nash Corporation. “The Nerites’ technology will integrate well with Kensey Nash’s existing biomaterial capabilities and technologies, providing many opportunities for next generation products currently in the market and expanding our development pipeline as well as opportunities for additional strategic partnerships. We will initially target the hernia and dura repair markets,” he concluded.

“We are very pleased with this transaction and the commitment Kensey Nash is making to broadly commercialize products based on our technology,” commented Shaun C. Lonergan, President and CEO of Nerites Corporation. “We are proud of our Madison team and excited about the impact this technology can have on improving the practice of medicine. We believe the expertise and resources Kensey Nash brings to the table will really enhance that opportunity,” he added.

The Nerites’ technology is inspired by the proteins secreted by marine mussels for bonding to underwater surfaces. Research conducted on these adhesive proteins by Phillip Messersmith, Ph.D., of Northwestern University identified the key components believed to be primarily responsible for the adhesive properties. Synthetic versions of these key components have been developed to create biomaterials capable of binding to tissue and other materials in aqueous surgical environments. Nerites has funded their activities through $11 million from venture capital and private investors, as well as an additional $5 million in NIH and NSF Small Business Innovation Research (SBIR) grants.

Conference Call and Webcast.
The Company will discuss this transaction on the teleconference it is hosting with respect to its operating results for its second quarter of fiscal 2011 on Tuesday, February 1, 2011 at 9:00 A.M. Eastern Time. To participate in the teleconference call, dial 1-612-332-1020. The teleconference call will also be available for replay starting Tuesday, February 1, 2011 at 11:00 A.M. Eastern Time through Tuesday, February 8, 2011 at 11:59 P.M. Eastern Time by dialing 1-800-475-6701 with an access code of 187632. Individuals interested in listening to the teleconference may also do so over the Internet at www.kenseynash.com. To listen to the live teleconference call, please go to the www.kenseynash.com website and choose the Investor Relations page. Please allow 15 minutes prior to the start of the call to register and download and/or install any necessary software. A replay of the teleconference will be archived on the www.kenseynash.com website and may be accessed following the teleconference.

About Kensey Nash Corporation
Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including, the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.

Kensey Nash Cautionary Note for Forward-Looking Statements.
This press release contains forward-looking statements, including statements regarding potential benefits of the acquisition of assets of Nerites’ that reflect the current expectations of Kensey Nash Corporation (the “Company”) about its prospects and opportunities. The Company has tried to identify these forward looking statements by using words such as “expect,” “anticipate,” “estimate,” “plan,” “will,” “would,” “should,” “forecast,” “believe,” “guidance,” “projection” or similar expressions, but these words are not the exclusive means for identifying such statements. The Company cautions that a number of risks, uncertainties and other important factors could cause the Company’s actual results to differ materially from those in the forward-looking statements including, without limitation, the Company’s success in and the uncertainty of the required time and efforts associated with its research and development efforts based upon the adhesive-based biomaterials technology acquired from Nerites, completion of clinical trials in both the U.S. and Europe to support regulatory approval of any products that employ the technology, the Company’s success in distributing its products that employ that technology, the Company’s success in distributing any such products into the marketplace and competition from other adhesive technologies, as well as tax and other risks associated with healthcare reform, economic conditions and foreign currency fluctuations. For a detailed discussion of factors that could affect the Company’s future operating results, please see the Company’s SEC filings, including the disclosures under “Risk Factors” in those filings. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events or for any other reason.

SOURCE Kensey Nash Corporation

For further information: Joseph Kaufmann, Kensey Nash Corporation, +1-484-713-2100

Calgary, Alberta August 13 2010 - Pure Technologies Ltd. (“Pure”) (TSX-V:PUR) announced today that it has concluded the purchase of The Pressure Pipe Inspection Company (“PPIC”) for up to CAD$34.9 million in cash and common stock of Pure.

PPIC, a privately-held company with headquarters in Mississauga, Ontario, is a leader in large-diameter water and wastewater pipeline condition assessment. PPIC is currently active in North America (including Mexico), South America, the Philippines and Hong Kong. For the fiscal year ended September 30, 2009, PPIC had revenues of $14.6 million.

The base purchase price is $30,000,000 with provision for a maximum additional payment of $4,900,000 should PPIC generate revenues of $24,900,000 for the fiscal year ended September 30, 2010. The amount of the additional payment will be reduced on a dollar-for-dollar basis for every dollar that fiscal 2010 revenues fall short of $24,900,000. The purchase price is based on a PPIC working capital balance of $800,000 at closing and will be adjusted up or down on a dollar-for-dollar basis depending on the actual working capital at closing. Consideration paid at closing was $8,955,776 in cash and Pure issued 3,782,476 shares valued at $4.44 per share which was negotiated as part of the transaction. This consideration is net of a holdback amount, which when released, would be paid in cash in the amount of $800,551 and a further 776,903 shares. Any additional payments will be paid approximately 29% in cash and 71% in Pure common stock with an attributed value of $4.44.

Following closing, Emerald Technology Ventures, PPIC’s largest shareholder, has the right to nominate one director to Pure’s Board of Directors. Subject to TSX Venture Exchange approval, Scott MacDonald, Partner with Emerald Technology Ventures, will join Pure’s Board of Directors.

Dr. Brian Mergelas, formerly the Chief Executive Officer of PPIC, is now Pure’s Senior Vice-President, Corporate Strategy & Development. Dr. Mergelas has published over fifty papers in academic and industry journals, and is a recognized expert in the field of pipeline condition assessment. He will be a key contributor to shaping Pure’s strategic direction and in identifying future opportunities to grow Pure’s business. He will also continue to play a leading role in the promotion of proactive asset management as a cost-effective strategy for bridging the infrastructure funding gap.

“Today is a very exciting day for our clients and employees as we bring together our two companies to create a world-class solutions provider,” said Dr. Brian Mergelas. “Both Pure and PPIC have always strived to provide the best possible condition assessment and monitoring solutions, and together we will be able to offer a greater knowledge base and a stronger portfolio to help our clients. As always, our success will continue to be anchored around building long-term relationships that provide exceptional value and build trust.”

Commenting on the transaction, Pure’s Chief Executive Officer, Mr. Peter Paulson, said:

“This is a significant milestone for Pure and for the international water technology sector. The combined Pure/PPIC entity will be a world leader in the field of condition assessment and asset management for water and wastewater pipelines. We are excited about the opportunity to work with Dr. Mergelas and his team as we continue to build awareness of the need for cost-effective strategies and solutions for the enormous challenges facing pipeline operators around the world. Working together, we will be able to deliver a cohesive and powerful message to the industry about the value of technology-driven proactive asset management. We are also looking forward to working with PPIC’s research and development team to accelerate the introduction of new condition assessment tools for pipelines.”

Pure expects that the highly complementary expertise and technologies resulting from the acquisition of PPIC will allow it to offer one of the most comprehensive suites of proprietary solutions to water and wastewater agencies around the world. PPIC’s leadership position in condition assessment fits well with Pure’s position as the primary provider of long-term monitoring solutions for pre-stressed pipelines. The recent introduction by PPIC of the PipeDiver(R) autonomous electromagnetic inspection technology, which allows unmanned inspection of prestressed concrete pipelines while in service, is a major advancement in the field and is complementary to Pure’s SoundPrint(R) AFO fibre-optic acoustic monitoring system. The combination of PPIC’s Sahara(R) with Pure’s SmartBall(R) means that operators of large-diameter pipelines will now be able to access a “one-stop shop” for leak detection solutions.

Over the past year or so, Pure has invested heavily in expanding its international presence with the establishment of a branch office in Abu Dhabi and a joint venture company in Hong Kong. Pure intends to use this network to disseminate both Pure’s and PPIC’s technologies and services cost-effectively and efficiently.

Canaccord Genuity acted as financial advisor to Pure on this transaction and Kirchner Private Capital Group acted as financial advisor to PPIC. Bennett Jones LLP acted as legal counsel to Pure and Heenan Blaikie LLP as legal counsel to PPIC and its shareholders.

About Pure Technologies Ltd.

Pure Technologies Ltd. is an international asset management technology and services company which has developed patented technologies for inspection, monitoring and management of critical infrastructure around the world. Pure’s business model incorporates four distinct but complementary business streams:

– Sales of proprietary monitoring technologies for pipelines, bridges
and structures (SoundPrint(R), SoundPrint(R) AFO);

– Recurring revenue from data analysis and site maintenance for these
technologies, and from technology licensing.

– Premium technical services including inspection, leak detection and
condition assessment (P-Wave(R), SmartBall(R), Sahara(R),
PipeDiver(R), PureRobotics(TM)).

– Specialized engineering services in areas related to asset
management, primarily in the area of pipeline condition assessment
for water and wastewater infrastructure (Openaka Corp., Price
Brothers UK Ltd, and Jason Consultants).
About Pressure Pipe Inspection Company

PPIC, a privately-held company with headquarters in Mississauga, Ontario, is a world leader in large-diameter water and wastewater pipeline condition assessment. PPIC was founded in 1997 to commercialize RFEC/TC, an electromagnetic inspection technology for prestressed concrete pipes developed by David Atherton, Professor of Physics at Queen’s University, Kingston, Ontario. In 2008, PPIC purchased the worldwide rights (excluding the United Kingdom and Ireland) to Sahara(R), a leak detection system for large-diameter pipelines developed by WRc plc.

Forward-Looking Statements

This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and Pure’s actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of Management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. In the context of any forward-looking information please refer to risk factors detailed in, as well as other information contained in, Pure’s filings with Securities Regulators (www.sedar.com).

“Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.”

(R) Registered Trademarks, property of Pure Technologies Ltd.